ADCY9 / AC9 Antibody

About the Target

ADCY9 / AC9 (Adenylyl cyclase 9) is the most divergent of the nine mammalian transmembrane adenylyl cyclase (AC) isoforms, characterized by its relative insensitivity to forskolin and a unique C-terminal extension (C2b) that suppresses enzymatic activity by occupying its catalytic and allosteric sites. Structurally, ADCY9 / AC9 consists of 12 transmembrane helices arranged in two domains (TM1-6 and TM7-12), a cytoplasmic catalytic core formed by C1 and C2 domains, and the distinctive C2b domain that elevates its Km for ATP upon Gαs activation. Depending on the literature source, ADCY9 may also be discussed as ADCY9 / AC9.

Reported cellular context includes cell membrane and membrane, which can matter when signal is compared across treatments or changing cell states. Following ADCY9 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

ADCY9 is commonly interpreted in the context of cardiovascular and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane and membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane and membrane across matched conditions
• changes linked to vascular, contractile, or hemodynamic cell-state cues
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ADCY9. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ADCY9 reflect biology rather than handling. When interpreting ADCY9, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep ADCY9 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.